Dublin, May 29, 2023 (GLOBE NEWSWIRE) -- The "Global Colonoscopy Bowel Preparation Drugs Market Size, Trends & Growth Opportunity, by Drug Type, by Distribution Channel, Regional Outlook, Competitive Market Share & Forecast, 2022 - 2027." report has been added to ResearchAndMarkets.com's offering.
Global Colonoscopy Bowel Preparation Drugs Market was valued at USD 2,500.9 million in 2021 and is expected to reach USD 4,500.7 million by 2027, at a CAGR 7.22% from 2022-2027.
Colonoscopy is a type of screening test that is used for detection of colorectal cancer. It is dependent on pre pre-procedure which is called colonoscopy bowel preparation, in this cleansing of colon is done in the patient's colonoscopy.
Colonoscopy bowel preparation drugs are classified into various types such as Isomotic Agents, Hypersosmotic Agents, Hyposmotic Agents, and Combination Agents. It involves taking a laxative medication & restricting one's diet to clear the colon of stool so that the doctor can clearly see any abnormal areas in one's colon during the procedure.
Market Drivers
Increasing research & development activities is the key driving factor which is expected to propel the global colonoscopy bowel preparation drugs market growth. For instance, in December 2019, ColonaryConcepts had announced the Phase III clinical trial of its Edible Colonoscopy preparation for bowel cleansing.
Furthermore, adoption of collaboration activities by key vendors will positively influence the market growth. Moreover, rising prevalence of colorectal cancer is expected to boost the market growth during this forecast period.
Market Restraints
However, occurrence of side effects like abdominal pain, abdominal swelling, nausea, and vomiting are the challenging factors which are expected to hinder the global colonoscopy bowel preparation market growth in future.
Market Segmentation
The Global Colonoscopy Bowel Preparation Drugs Market is segmented into drug type such as Isomotic Agents (High-volume Polyethylene Glycol Preparations, Sulfate-free PEG-ELS, Low-volume PEG Preparations), Hypersosmotic Agents (Oral sodium Sulfate, Magnesium Citrate, Sodium Phosphate), Hyposmotic Agents, and Combination Agent.
Further, the market is segmented into distribution channels such as Hospital Pharmacies, Retail Pharmacies, and Others.
Regional Analysis
The Global Colonoscopy Bowel Preparation Drugs Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The North American region is expected to register a robust revenue CAGR over the forecast period 2027 owing to the increasing rate of colorectal cancer in the American market. Industry key players are likely to adopt collaborations and acquisition tactics, propelling the market growth.
Whereas, the European region accounted for the largest revenue share, and the trend is expected to continue during the forecast period owing to significant companies using inorganic growth tactics.
Market Taxonomy
By Drug Type
- Isomotic Agents
- High-volume Polyethylene Glycol Preparations
- Sulfate-free PEG-ELS
- Low-volume PEG Preparations
- Hypersosmotic Agents
- Oral sodium Sulfate
- Magnesium Citrate
- Sodium Phosphate
- Hyposmotic Agents
- Combination Agent
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Global Colonoscopy Bowel Preparation Drugs Market Outlook
5 Global Colonoscopy Bowel Preparation Drugs Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Global Colonoscopy Bowel Preparation Drugs Market Share Analysis, By Type
5.3 Global Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Type
5.3.1 Isomotic Agents
5.3.1.1 High-Volume Polyethylene Glycol Preparations
5.3.1.2 Sulfate-free-PEG-ELS
5.3.1.3 Low Volume PEG preparations
5.3.2 Hypersosmotic Agents
5.3.2.1 Oral Sodium Sulfate
5.3.2.2 Magnesium Citrate
5.3.2.3 Sodium Phosphate
5.3.3 Hyposmotic Agents
5.3.4 Combination Agents
6 Global Colonoscopy Bowel Preparation Drugs Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Colonoscopy Bowel Preparation Drugs Market Share Analysis, By Application
6.3 Global Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Application
6.3.1 Hospital Pharmacies
6.3.2 Retail Pharmacies
6.3.3 Others
7 Global Colonoscopy Bowel Preparation Drugs Market, By Region
7.1 Global Colonoscopy Bowel Preparation Drugs Market Share Analysis, By Region
7.2 Global Colonoscopy Bowel Preparation Drugs Market Share Analysis, By Region
7.3 Global Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Region
8 North America Colonoscopy Bowel Preparation Drugs Market Analysis and Forecast (2022 - 2027)
9 Europe Colonoscopy Bowel Preparation Drugs Market Analysis and Forecast (2022 - 2027)
10 Asia Pacific Colonoscopy Bowel Preparation Drugs Market Analysis and Forecast (2022 - 2027)
11 Latin America Colonoscopy Bowel Preparation Drugs Market Analysis and Forecast (2022 - 2027)
12 Middle East Colonoscopy Bowel Preparation Drugs Market Analysis and Forecast (2022 - 2027)
13 Competitive Analysis
14 Company Profiles
Companies Mentioned
- Bayer AG
- ColonaryConcepts
- Bausch Health Companies Inc.
- Ferring B.V.
- Norgine B.V. KOREA PHARMA CO. Ltd.
- Braintree
- Others.
For more information about this report visit https://www.researchandmarkets.com/r/fdyxfl
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
